Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Sphingolipid metabolism is crucial for cancer cell death, survival, and therapy resistance.
• Dihydroceramide and ceramide are key sphingolipids linked to antiproliferative and cell death responses, respectively.
• Recent advances have illuminated sphingolipid metabolism's dysregulation in malignancy and cancer cell evasion tactics.

Purpose of the Study:

• To review sphingolipid enzymes dysregulated in cancer, with a focus on prostate cancer.
• To discuss inhibitors targeting sphingolipid metabolism to counteract prosurvival mechanisms.
• To explore sphingolipid-driven cancer cell escape mechanisms and therapeutic strategies.

Main Methods:

• Review of current literature on sphingolipid metabolism in cancer.
• Analysis of dysregulated sphingolipid enzymes in various cancers, particularly prostate cancer.
• Examination of inhibitors and combined strategies targeting sphingolipid metabolism.

Main Results:

• Identification of key sphingolipid enzymes implicated in cancer development and progression.
• Evaluation of therapeutic potential of sphingolipid metabolism inhibitors.
• Understanding of cancer cell resistance mechanisms related to sphingolipid pathways.

Conclusions:

• Dysregulation of sphingolipid metabolism is a significant factor in cancer survival and therapy resistance.
• Targeting sphingolipid metabolism, especially ceramide generation, presents a promising therapeutic avenue.
• Combining strategies to enhance ceramide production and prevent its clearance may overcome cancer evasion tactics.